Role of TGF-β1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer

Oncology Research

Volumn 18, Issue 1, 2009, Pages 41-45

  Singh, Hariom ^a   Jain, Meenu ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Cytokine; Polymorphism; Transforming growth factor

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA1; DEOXYCYTIDINE; THYMIDINE;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SMOKING; UTERINE CERVIX CANCER; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; INDIA; MIDDLE AGED; PATHOLOGY; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKELESS TOBACCO; UTERINE CERVIX TUMOR;

ADULT; DEOXYCYTIDINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INDIA; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SMOKING; THYMIDINE; TOBACCO, SMOKELESS; TRANSFORMING GROWTH FACTOR BETA1; UTERINE CERVICAL NEOPLASMS;

EID: 77950468116     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789745656     Document Type: Article

References (31)

1. Parkin, D. M.; Bray, F.; Ferla, J.; Pisani, P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94:153-156; 2001.
2. Sankaranarayanan, R.; Nene, B. M.; Dinshaw, K.; Rajkumar, R.; Shastri, S.; Wesley, R.; Basu, P.; Sharma, R.; Thara, S.; Budukh, A.; Parkin, D. M. Early detection of cervical cancer with visual inspection methods: A summary of completed and on-going studies in India. Salud Publica de Mexico 45:274-282; 2003.
3. Farzaneh, F.; Roberts, S.; Mandal, D.; Ollier, B.; Winters, U.; Kitchener, H. C.; Brabin, L. The IL-10-082G polymorphism is associated with clearance of HPV infection. BJOG 113:961-964; 2006.
4. Wallin, K. L.; Wiklund, F.; Angström, T.; Bergman, F.; Stendahl, U.; Wadell, G.; Hallmans, G.; Dillner, J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med. 341:1633-1638; 1999.
5. Petry, K. U.; Böhmer, G.; Iftner, T.; Flemming, P.; Stoll, M.; Schmidt, R. E. Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women. Gynecol. Oncol. 75:427-431; 1999.
6. Grande, J. P.; Melder, D. C.; Zinsmeister, A. R. Modulation of collagen gene expression by cytokines: Stimulatory effect of transforming growth factor-beta1, with divergent effects of epidermal growth factor and tumor necrosis factor-alpha on collagen type I and collagen type IV. J. Lab. Clin. Med. 130:476-486; 1997.
7. Massagué, J.; Weis-Garcia, F. Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals. Cancer Surv. 27:41-64; 1996.
8. Sporn, M. B.; Roberts, A. B. Transforming growth factor-beta: Recent progress and new challenges. J. Cell Biol. 119:1017-1021; 1992.
9. Massagué, J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:753-791; 1998.
10. Caserta, T. M.; Knisley, A. A.; Tan, F. K.; Arnett, F. C.; Brown, T. L. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet. 47:359-363; 2004.
11. Ewart-Toland, A.; Chan, J. M.; Yuan, J.; Balmain, A.; Ma, J. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol. Biomarkers Prev. 13:759-764; 2004.
12. Hsieh, Y. Y.; Chang, C. C.; Tsai, F. J.; Peng, C. T.; Yeh, L. S.; Lin, C. C. Polymorphism for transforming growth factor beta 1-509 (TGF-B1-509): Association with endometriosis. Biochem. Genet. 43:203-210; 2005.
13. Wei, Y. S.; Zhu, Y. H.; Du, B.; Yang, Z. H.; Liang, W. B.; Lv, M. L.; Kuang, X. H.; Tai, S. H.; Zhao, Y.; Zhang, L. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin. Chim. Acta 380:165-169; 2007.
14. Shepperd, J. H. FIGO staging of gynecologic cancers; cervical and vulva. Int. J. Gynecol. Cancer 5:319; 1995.
15. Miller, S. A.; Dykes, D. D.; Polesky, H. F. A salting procedure for extracting DNA from nucleated cells. Nucleic Acid Res. 16:1215; 1988.
16. Zhang, J.; Jin, X.; Fang, S.; Wang, R.; Li, Y.; Wang, N.; Guo, W.; Wang, Y.; Wen, D.; Wei, L.; Dong, Z.; Kuang, G. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26:1748-1753; 2005.
17. Stanczuk, G. A.; Tswana, S. A.; Bergstrom, S.; Sibanda, E. N. Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur. J. Immunogenet. 29:417-421; 2002.
18. Jin, Q.; Hemminki, K.; Grzybowska, E.; Klaes, R.; Söderberg, M.; Zientek, H.; Rogozinska-Szczepka, J.; Utracka-Hutka, B.; Pamula, J.; Pekala, W. A. Polymorphisms and haplotype structures in genes for transforming growth factor beta1and its receptors in familial and unselected breast cancers. Int. J. Cancer 112:94-99; 2004.
19. Kim, Y. J.; Lee, H. S.; Im, J. P.; Min, B. H.; Kim, H. D.; Jeong, J. B.; Yoon, J. H.; Kim, C. Y.; Kim, M. S.; Kim, J. Y.; Jung, J. H.; Kimm, L. H.; Park, B. L.; Shin, H. D. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp. Mol. Med. 35:196-202; 2003.
20. Jin, G.; Wang, L.; Chen, W.; Hu, Z.; Zhou, Y.; Tan, Y.; Wang, J.; Hua, Z.; Ding, W.; Shen, J.; Zhang, Z.; Wang, X.; Xu, Y.; Shen, H. Variant alleles ofTGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int. J. Cancer 120:1330-1335; 2007.
21. Shin, A.; Shu, X. O.; Cai, Q.; Gao, Y. T.; Zheng, W. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: A possible dual role at different cancer stages. Cancer Epidemiol. Biomarkers Prev. 14:1567-1570; 2005.
22. Tang, W.; Yang, L.; Yang, Y. C.; Leng, S. X.; Elias, J. A. Transforming growth factor beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J. Biol. Chem. 273:5506-5513; 1998.
23. Pierce, Jr., D. F.; Gorska, A. E.; Chytil, A.; Meise, K. S.; Page, D. L.; Coffey, Jr., R. J.; Moses, H. L. Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc. Natl. Acad. Sci. USA 92:4254-4258; 1995.
24. Sovak, M. A.; Arsura, M.; Zanieski, G.; Kavanagh, K. T.; Sonenshein, G. E. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. Cell Growth Differ. 10:537-544; 1999.
25. Benson, J. R. Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncol. 5:229-239; 2004.
26. De Ruyck, K.; Van Eijkeren, M.; Claes, K.; Bacher, K.; Vral, A.; De Neve, W.; Thierens, H. TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. Int. J. Radiat. Oncol. Biol. Phys. 65:1240-1248; 2006.
27. Hellberg, D.; Nilsson, S.; Haley, N. J.; Hoffman, D.; Wynder, E. Smoking and cervical intraepithelial neoplasia: Nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am. J. Obstet. Gynecol. 158:910-913; 1988.
28. Sedlacek, T. V. Advances in the diagnosis and treatment of human papillomavirus infections. Clin. Obstet. Gynecol. 42:206-220; 1999.
29. Kataja, V.; Syrjänen, S.; Yliskoski, M.; Hippelïnen, M.; Väyrynen, M.; Saarikoski, S.; Mäntyjärvi, R.; Jokela, V.; Salonen, J. T.; Syrjänen, K. Risk factors associated with cervical human papillomavirus infections: A case control study. Am. J. Epidemiol. 138:735-745; 1993.
30. Trimble, C. L.; Genkinger, J. M.; Burke, A. E.; Hoffman, S. C.; Helzlsouer, K. J.; Diener-West, M.; Comstock, G. W.; Alberg, A. J. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet. Gynecol. 105:174-181; 2005.
31. Blobe, G. C.; Schiemann, W. P.; Lodish, H. F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342:1350; 2000.